4,033
Views
34
CrossRef citations to date
0
Altmetric
Articles

Navigating HIV citizenship: identities, risks and biological citizenship in the treatment as prevention era

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-16 | Received 27 Feb 2018, Accepted 17 Jan 2019, Published online: 31 Jan 2019

References

  • Bernard, E. (2008, 5 August). Swiss statement that ‘undetectable equals uninfectious’ creates more controversy in Mexico City. aidsmap.
  • Beyrer, C., Birx, D. L., Bekker, L.-G., Barré-Sinoussi, F., Cahn, P., Dybul, M. R., … Montaner, J. S. G. (2015). The Vancouver consensus: Antiretroviral medicines, medical evidence, and political will. The Lancet, 386(9993), 505–507. Retrieved from http://www.sciencedirect.com/science/article/pii/S0140673615614581.
  • BHIVA. (2014). British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Medicine, 15(Suppl. 1), 1–85.
  • Blondell, S., Kitter, B., Griffin, M., & Durham, J. (2015). Barriers and facilitators to HIV testing in migrants in high-income countries: A systematic review. AIDS and Behavior, 19, 2012–2024.
  • Boseley, S. (2016, August 3). PrEP HIV drugs: Fight for limited NHS funds takes unedifying turn. The Guardian. Retrieved from https://www.theguardian.com/society/2016/aug/03/prep-hiv-drugs-fight-for-limited-nhs-funds-takes-unedifying-turn
  • Campbell, D. (2016, April 22). Smokers and obese people ‘soft targets’ for NHS savings, say surgeons. The Guardian. Retrieved from https://www.theguardian.com/society/2016/apr/22/smokers-obese-people-soft-targets-nhs-savings-surgeons
  • Carter, A., Lachowsky, N., Rich, A., Forrest, J. I., Sereda, P., Cui, Z., … Hogg, R. S. (2015). Gay and bisexual men’s awareness and knowledge of treatment as prevention: Findings from the Momentum Health Study in Vancouver, Canada. Journal of the International AIDS Society, 18(1): 20039.
  • Chinouya, M., & Davidson, O. (2003). The Padare Project: Assessing health-related knowledge, attitudes and behaviours of HIV-positive Africans accessing services in north central London. London. Retrieved from http://researchonline.lshtm.ac.uk/19288/
  • Churchill, D., Waters, L., Ahmed, N., Angus, B., Boffito, M., Bower, M., ...Winston, A. (2015). BHIVA guidelines for the treatment of HIV-1 positive adults with ART 2015, British HIV Association (BHIVA), London, UK.
  • Clarke, A. E., Mamo, L., Fosket, J. R., & Shim, J. K. (Eds.). (2010). Biomedicalization: Technoscience, health and illness in the U.S. Durham, NC: Duke University Press.
  • Cohen, M. S., Chen, Y. Q., McCauley, M., et al. (2015) Final results of the HPTN 052 randomized controlled trial: Antiretroviral therapy prevents HIV transmission. Paper presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, Canada.
  • Dodds, C., Mugweni, E., Phillips, G., Park, C., Young, I., Fakoya, F., Wayal, S., McDaid, L., Sachikonye, M., Chwaula, J., Flowers, P., & Burns, F. (2018). Acceptability of HIV self-sampling kits (TINY vial) among people of black African ethnicity in the UK: A qualitative study. BMC Public Health, 18, 499–512.
  • Elford, J., Sherr, L., Adam, P., Crawford, J., Kippax, S., Prestage, G, Rawstorne, P. (2003). HIV treatments optimism among gay men: An international perspective. JAIDS, 32(5), 545–550.
  • Flowers, P. (2001). Gay men and HIV/AIDS risk management. Health, 5(1), 50–75.
  • Flowers, P. (2010). HIV transitions: Consequences for the self in an era of medicalisation. In M. Davis & C. Squire (Eds.), HIV treatment and prevention technologies in international perspective (pp. 109–125). Basingtsoke: Palgrave Macmillan.
  • Flowers, P., & Davis, M. (2013). Obstinate essentialism: Identity transformation amongst gay men living with HIV. Psychology of Sexualities, 4(3), 283–295.
  • Freire, P. (1970). Pedagogy of the oppressed. New York: Continuum.
  • GNP+. (2017, May 1). Follow up on previous article: On fear, infectiousness, undetectability. Retrieved from http://www.gnpplus.net/follow-up-on-previous-article-on-fear-infectiousness-undetectability/
  • Grace, D., Chown, S. A., Kwag, M., Steinberg, M., Lim, E., & Gilbert, M. (2015). Becoming “undetectable”: Longitudinal narratives of gay men’s sex lives after a recent HIV diagnosis. AIDS Education and Prevention, 27(4), 333–349.
  • Happe, K., Johson, J., & Levina, M. (2018). Introduction. In K. Happe, J. Johson, & M. Levina (Eds.), Bio-citizenship: The politics of bodies, governance and power. New York: New York University Press (pp 1-17).
  • INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373(9), 795–807.
  • Keogh, P. (2017). Embodied, clinical and pharmaceutical uncertainty: People with HIV anticipate the feasibility of HIV treatment as prevention (TasP). Crtical Public Health, 27(1), 63–74.
  • Kirwan, P., Chau, C., Brown, A., Gill, O., Delphech, V.,and contributors (2016). HIV in the UK: 2016 report. Public Health England, London.
  • Mason, J. (2002). Qualitative researching. London: Sage Publications.
  • Newman, C. E., Mao, L., Persson, A., Holt, M., Slavin, S., Kidd, M. R., … de Wit, J. (2015a). ‘Not until I’m absolutely half-dead and have to:’Accounting for non-use of antiretroviral therapy in semi-structured interviews with people living with HIV in Australia. AIDS Patient Care and STDs, 29(5), 267–278.
  • Newman, C. E., Persson, A., Miller, A., & Brown, R. J. (2015b). Just take your medicine and everything will be fine: Responsibilisation narratives in accounts of transitioning young people with HIV into adult care services in Australia. AIDS Care, 29 (5),1–6.
  • Nguyen, V. K. (2010). The republic of therapy: Triage and sovereignty in West Africa’s time of AIDS. Durham, NC: Duke University Press.
  • Paparini, S., & Rhodes, T. (2016). The biopolitics of engagement and the HIV cascade of care: A synthesis of the literature on patient citizenship and antiretroviral therapy. Critical Public Health, 26(5), 501–517.
  • Persson, A. (2013). Non/infectious corporealities: Tensions in the biomedical era of ‘HIV normalisation’. Sociology of Health & Illness, 35(7), 1065–1079.
  • Persson, A. (2015). ‘The world has changed’: Pharmaceutical citizenship and the reimagining of serodiscordant sexuality among couples with mixed HIV status in Australia. Sociology of Health & Illness, 38 (3), 380-395.
  • Petersen, A. R., & Lupton, D. (1996). The new public health: Discourses, knowledges, strategies. London: SAGE Publications.
  • Petryna, A. (2002). Life exposed: Biological citizens after chernobyl. Princeton, NJ: Princeton University Press.
  • Petryna, A., & Follis, K. (2015). Risks of citizenship and fault lines of survival. Annual Review of Anthropology, 44, 401–417.
  • Pollock, A. (2012). Medicating race: Heart disease and durable preoccupations with difference. Durham, North Carolina: Duke University Press.
  • Prevention Access Campaign. (2016). U=U Consensus Statement.
  • Rennie, S., Siedner, M., Tucker, J., & Moodley, K. (2015). The ethics of talking about ‘HIV cure’. BMC Medical Ethics, 16(18). DOI:10.1186/s12910-015-0013-0
  • Robins, S., & Von Lieres, B. (2004). Remaking citizenship, unmaking marginalization: The treatment action campaign in post-apartheid South Africa. Canadian Journal of African Studies/La Revue canadienne des études africaines, 38(3), 575–586.
  • Rose, N. (2007). The politics of life itself: Biomedicine, power and subjectivity in the twenty-first century. Oxford and Princeton, NJ: Princeton University Press.
  • Rosengarten, M., Race, K., & Kippax, S. (2000). ‘Touch wood, everything will be ok’: Gay men’s understandings of clinical markers in sexual practice. Sydney, Australia: National Centre in HIV Social Research.
  • Russell, S., Namukwaya, S., Zalwango, F., & Seeley, J. (2016). The framing and fashioning of therapeutic citizenship among people living with HIV taking antiretroviral therapy in Uganda. Qualitative Health Research, 26(11), 1447–1458.
  • Sabin, C. A., Cooper, D. A., Collins, S., & Schechter, M. (2013). Rating evidence in treatment guidelines: A case example of when to initiate combination antiretroviral therapy (cART) in HIV-positive asymptomatic persons. AIDS, 27(12), 1839–1846.
  • Silverman, D. (2000). Doing qualitative research: A practical handbook. London: Sage.
  • Sparke, M. (2017). Austerity and the embodiment of neoliberalism as ill-health: Towards a theory of sub-biological citizenship. Social Science & Medicine, 187, 287–295.
  • Squire, C. (2013). Living with HIV and ARVs: Three-letter lives. Basingstoke: Palgrave MacMillan.
  • Thomas, F., Aggleton, P., & Anderson, J. (2010). ‘If I cannot access services, then there is no reason for me to test’: The impacts of health service charges on HIV testing and treatment amongst migrants in England. AIDS Care, 22(4), 526–531.
  • Webster, A. (2007). Health, technology and society: A sociological critique. London: Palgrave MacMillan.
  • Young, I., Flowers, P., & McDaid, L. (2015). Key factors in the acceptability of treatment as prevention (TasP) in Scotland: A qualitative study with communities affected by HIV. Sexually Transmitted Infections, 91(4), 269–274.
  • Young, I., Flowers, P., & McDaid, L. (2016). Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention. Sociology of Health & Illness, 30(3), 411–425.